Company name: Solaris Nutraceuticals
Description: Operator of a medical technology company intended to deliver an environmentally friendly, sun-grown medicinal grade cannabis. The company’s medical technology caters to the cultivation of medical cannabis and researching on developing medicines and treatments for pain management along with a number of other medical conditions and specific plant-based nutraceuticals.
Industry: Healthcare | Group: Other Healthcare | Code:
State: New South Wales
Start up capital raised (USD Million):
Business status: Startup
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was formed as a joint venture between MYM Nutraceuticals (CSE: MYM) and PUF Ventures (CSE: PUF) on an undisclosed date. With this deal, the companies expect that export of cannabis products from Australia will be big business and could possibly outpace domestic sales in Canada.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation:
Last known valuation date: